Evidence map›Paper›PMID 22577363›Full record

ArticlePLoS genetics2012

Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.

Haoyan Chen, Genki Hayashi, Olivia Y Lai, Alexander Dilthey, Peter J Kuebler, Tami V Wong, Maureen P Martin, Marcelo A Fernandez Vina, Gil McVean, Matthias Wabl and 8 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. HLA Alleles BFrontiers in immunology · 2021
    Article
  16. Genome-wide Study Identifies Association between HLA-BAmerican journal of human genetics · 2020
    Article
  17. Role of Innate Immune Cells in Psoriasis.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Haoyan ChenDepartment of Dermatology, University of California San Francisco, San Francisco, California, USA.
Genki Hayashi
Olivia Y Lai
Alexander Dilthey
Peter J Kuebler
Tami V Wong
Maureen P Martin
Marcelo A Fernandez Vina
Gil McVean
Matthias Wabl
Kieron S Leslie
Toby Maurer
Jeffrey N Martin
Steven G Deeks
Mary Carrington
Anne M Bowcock
Douglas F Nixon
Wilson Liao
University of California, San Francisco · USNational Cancer Institute · USUniversity of Oxford · GBStanford University · USWashington University in St. Louis · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
Effects of genetic polymorphism in MHC, KIR, and related loci on human diseaseZIABC010791 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRINGTON, MARY N. · 2009 to 2025
$18.2M
Specimen Acquisition and Distribution CoreP01AI076174 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL · 2008 to 2012
$10.9M
Genome-Wide SNP Association in PsoriasisR01AR050266 · NIAMS · WASHINGTON UNIVERSITY · PI BOWCOCK, ANNE MARY · 2007 to 2016
$5.7M
GENE TARGETED MICE WITH A SIMPLIFIED IMMUNE SYSTEMR01AI041570 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WABL, MATTHIAS R · 1998 to 2014
$4.6M
The impact of early antiretroviral therapy on HIV persistence and inflammationR01AI087145 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2009 to 2010
$1.6M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
Genetic Analysis of the TNF Pathway in PsoriasisK08AR057763 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIAO, WILSON · 2010 to 2014
$599k
CCR NIH HHS HHSN261200800001CIntramural NIH HHSNCI NIH HHS HHSN261200800001ENCRR NIH HHS UL1 RR024131NIAID NIH HHS AI 76174NIAID NIH HHS K24 AI069994NIAID NIH HHS K24AI069994NIAID NIH HHS P01 AI076174NIAID NIH HHS P0 AI27763NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI041570NIAID NIH HHS R01AI041570NIAID NIH HHS R01 AI087145NIAID NIH HHS R24 AI067039NIAMS NIH HHS 5K08AR057763-02NIAMS NIH HHS AR050266NIAMS NIH HHS K08 AR057763NIAMS NIH HHS R01 AR050266Wellcome Trust 076113Wellcome Trust 085475Wellcome Trust 090532
6 · The paper itself

Abstract

An important paradigm in evolutionary genetics is that of a delicate balance between genetic variants that favorably boost host control of infection but which may unfavorably increase susceptibility to autoimmune disease. Here, we investigated whether patients with psoriasis, a common immune-mediated disease of the skin, are enriched for genetic variants that limit the ability of HIV-1 virus to replicate after infection. We analyzed the HLA class I and class II alleles of 1,727 Caucasian psoriasis cases and 3,581 controls and found that psoriasis patients are significantly more likely than controls to have gene variants that are protective against HIV-1 disease. This includes several HLA class I alleles associated with HIV-1 control; amino acid residues at HLA-B positions 67, 70, and 97 that mediate HIV-1 peptide binding; and the deletion polymorphism rs67384697 associated with high surface expression of HLA-C. We also found that the compound genotype KIR3DS1 plus HLA-B Bw4-80I, which respectively encode a natural killer cell activating receptor and its putative ligand, significantly increased psoriasis susceptibility. This compound genotype has also been associated with delay of progression to AIDS. Together, our results suggest that genetic variants that contribute to anti-viral immunity may predispose to the development of psoriasis.

Indexed as

Genes, MHC Class IGenes, MHC Class IIGenetic Association StudiesGenetic Predisposition to DiseaseHIV-1HIV InfectionsHLA-B AntigensHLA-C AntigensHumansKiller Cells, NaturalPolymorphism, GeneticProtein BindingPsoriasisReceptors, KIR3DS1HLA-B AntigensHLA-C AntigensReceptors, KIR3DS1

Identifiers

PMID22577363
PMCPMC3343879
OpenAlexW2036348602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.